AADAC

protein-coding

arylacetamide deacetylase, the group of Lipases|Arylacetamide deacetylase family

Gene summary

Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens [provided by RefSeq, Jul 2008]

MANE transcript

NM_001086.3

Inheritance

—

ClinVar variants

U:55B:2

Top phenotype

—

gnomAD constraint

pLI —, LoF o/e 0.48

Max pathogenic AF

—

Genomic locus

chr3:151,814,073-151,828,488

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~14.4 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Tourette syndromeNO_KNOWN

Inheritance Pattern: Unknown

Disease ID:MONDO:0007661

Submitter: Labcorp Genetics (formerly Invitae)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to AADAC variants in ClinVar

2 Conditions Cataloged
not specifiedTotal: 54
not providedTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001086.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
missense
54
clinvar
1
clinvar
55
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total00552057
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 25 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001086.3RefSeqNP_001077.25MANE Select
ENST00000232892.12EnsemblENSP00000232892.65MANE Select
ENST00000488869.1EnsemblENSP00000419620.14Standard
ENST00000488869.2EnsemblENSP00000419620.14Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Phase I - Functionalization of compounds
  • Biological oxidations
  • Metabolism

Biological Process

  • xenobiotic metabolic process
  • positive regulation of triglyceride catabolic process

Molecular Function

  • catalytic activity
  • triglyceride lipase activity
  • lipase activity
  • serine hydrolase activity
  • deacetylase activity

Cellular Component

  • endoplasmic reticulum membrane
  • integral component of membrane
  • organelle membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000232892
Coding exons
5
Length
14452
Individuals with no LoFs
125676
Homozygous LoFs
0
Heterozygous LoFs
48
Defined
125724
p
0.000191
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.3641952100.9290.00001062587
Missense (PolyPhen)5867.3160.86161871
Synonymous-0.5998780.21.090.00000429777
Loss of Function1.71612.50.4785.24e-7181

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000620.000062rare
Latino/Admixed American0.0000580.000058rare
Ashkenazi Jewish00.0absent
East Asian0.00170.0017notable
Finnish00.0absent
European (Non-Finnish)0.0000530.000053rare
South Asian0.000230.00023rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Displays cellular triglyceride lipase activity in liver, increases the levels of intracellular fatty acids derived from the hydrolysis of newly formed triglyceride stores and plays a role in very low-density lipoprotein assembly. Displays serine esterase activity in liver. Deacetylates a variety of arylacetamide substrates, including xenobiotic compounds and procarcinogens, converting them to the primary arylamide compounds and increasing their toxicity. {ECO:0000269|PubMed:17936933, ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:23542347}.;

Recessive Scores

pRec
0.0773

Intolerance Scores

LoFtool
0.819
RVIS EVS
-0.09
RVIS percentile EVS
46.92

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.673

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.